Article & Resources

transparent image

Prostate biopsy: a change of approach

transparent image

What every couple should know about prostate cancer…

transparent image

A new report entitled ‘Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit – the ‘Fry‐Turnbull’ effect,’ published in the British Journal of Urology International (BJUI,) highlights the effects of celebrity endorsement of cancer screening and the importance this has in raising public awareness.

transparent image

A new research paper recently published gives further weight to the eradication of the transrectal (TR) prostate biopsy from the prostate cancer pathway.

transparent image

New study adds evidence to the important role of MRI & systematic biopsy in prostate cancer diagnosis

transparent image

Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control

transparent image

BXTAccelyon wins 2020 MedTech Breakthrough Award

transparent image

Customer Feedback Survey

transparent image

The influential role of brachytherapy in prostate cancer care

transparent image

Like Bill Turnbull and Stephen Fry, Russell is keen to make more men aware of the importance of getting themselves checked early and regularly.

transparent image

David Robb was a 68-year-old retired secondary school teacher from Peebles, Scotland when he was diagnosed with prostate cancer last Summer.

transparent image

“Before having a prostate cancer biopsy, I’d demand an MRI scan”

transparent image

Cancer alliance moves towards the eradication of Trus prostate cancer biopsy

transparent image

Prostate Cancer won’t wait for the pandemic to end

transparent image

THE SOUTH WEST CANCER ALLIANCE MOVES TOWARDS ERADICATION OF ‘TRUS’ PROSTATE CANCER BIOPSY

transparent image

Risk and Reward: why the specialist urology nurse is a role worth fighting for

transparent image

BXTAccelyon and Hitachi Medical Systems to support #TRexit

transparent image

BXTACCELYON BECOMES GLOBAL DISTRIBUTION PARTNER FOR NEW ONLINE PROSTATE MRI SELF-LEARNING TOOL, MRI PRO, TO ENHANCE PROSTATE CANCER DIAGNOSIS

transparent image

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

transparent image

State of the Art Stokes Centre for Urology to host Two-day Uro-Oncology Masterclass covering latest Innovations in Prostate Cancer Pathway

transparent image

Proton therapy for prostate cancer: does the evidence support the hype?

transparent image

All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy.

transparent image

Forget Brexit, it’s all about TRexit – and urology nurses are leading the way

transparent image

The National Prostate Cancer Audit (NPCA) published results

transparent image

LDR Brachytherapy – Latest study indicates acceptable GU toxicity in patients with prostate cancer treated with permanent seed implantation (PI)

transparent image

BXTAccelyon welcomes Kalpesh Makvana to the team

transparent image

Exemplary customer service from the team at BXTAccelyon

transparent image

BXTAccelyon addresses concerns that patients may be misled by news of HDR brachytherapy monotreatment

transparent image

Prostate cancer in Scotland: an evolutionary journey By Karen Walker, Clinical Nurse Specialist,Edinburgh Cancer Centre

transparent image

Chris was diagnosed with prostate cancer at the age of 67, having previously been treated for testicular cancer in 1976. His treatment pathway took many turns and below is his story.

transparent image

Open Letter to the Rt Hon Matt Hancock MP – Re: Time for ‘TREXIT’

transparent image

First PP course for Urology Nurses Practitioners and Registrars

transparent image

Chris Stone, 66 – A Patient Experience

transparent image

Time for change: Trexit

transparent image

Kevin Darragh began his prostate cancer treatment journey back in December 2012. After researching and discussing treatment options with those close to him, Kevin decided on brachytherapy

transparent image

John Morris’ story is an example of how far prostate cancer diagnosis and treatment, as well as men’s attitudes to the disease, have evolved in the last 10 years. It also proves the validity of low dose rate brachytherapy (LDR-B) as a long-standing, clinically proven treatment option with minimal quality of live side effects compared to other treatments

transparent image

BXTAccelyon attend the 9th Annual Urology in General Practice (UroGP) Symposium 2018

transparent image

LDR Brachytherapy: A minimally invasive curative treatment with excellent oncological and functional outcomes

transparent image

Galway’s success challenges common preconceptions about LDR brachytherapy

transparent image

Prostate Cancer: Men need to be given more control over their treatment options

transparent image

BXTAccelyon’s programme of upcoming events

transparent image

Prostate cancer Awareness Month – Australia

transparent image

Taxi for cancer: Cab driver Andy hails the day a fare saved his life

transparent image

Making informed treatment decisions

transparent image

The NHS turns 70!

transparent image

Challenging default clinical practice for prostate cancer

transparent image

BXTAccelyon set to exhibit at BAUS 2018

transparent image

Better Quality of life scores after brachytherapy in comparison to radical prostatectomy

transparent image

Theresa May’s announcement of £75m plans to drive prostate cancer research

transparent image

The influential role of GPs – and brachytherapy – in prostate cancer care

transparent image

Ascending to the Next Level

transparent image

Is this the prostate cancer test all men at risk should demand?

transparent image

Edinburgh Cancer Centre: supporting open thinking in prostate cancer treatment options

transparent image

Living with Cancer: 5 Important Questions

transparent image

Petition: National Prostate Cancer Screening for the UK

transparent image

Five genetically-different types of prostate cancer identified

transparent image

ASCENDE RT study: intermediate and high risk prostate cancer patients have double the survival chance with brachytherapy seeds

transparent image

Implants boost odds of halting prostate cancer: Men treated with radioactive ‘seeds’ twice as likely to find disease has stabilised after five years

transparent image

Low dose treatment for prostate cancer may be twice as good

transparent image

Trial of radioactive implants offers improved prostate cancer survival

Sorry, there are currently no posts with that category.

Join the conversation

Have you been diagnosed with prostate cancer?

We’d appreciate 5 minutes of your time to answer our questionnaire